Laminar Pharma Alternatives & Competitors
12 companies similar to Laminar Pharma — Biopharmaceutical company performing discovery, rational design and initial clin...
Io Therapeutics
Io therapeutics focuses on developing drugs that target nuclear receptors in order to trea...
Serina Therapeutics, Inc.
We have the next generation in polymer therapeutics. Go to www.serinatherapeutics.com and...
Huntsville, United States
OncoSynergy
Physician-founded, patient-focused.
Stamford, United States
Siren Biotechnology
Universal AAV immuno-gene therapy for cancer
San Francisco, United Sta...
Track all Laminar Pharma competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
AgenT
Detect Alzheimer's earlier, when it could be prevented
Paris, France
Resilience Care
Shaping the future of personalized medicine
Paris, France
Teon Therapeutics Inc.
Teon is a clinical company targeting metabolic signaling pathways and pioneering the devel...
Redwood City, United Stat...
ARTBIO
Channeling Energy. Changing Lives.
Cambridge, United States
Convergent Therapeutics, Inc.
Developing next-generation targeted combination therapies to advance the care of cancer pa...
Cambridge, United States
DIADEM SpA
To improve clinicians/patient understanding about risk of Dementia/Alzheimer’s to enable e...
London, United Kingdom
Imvax, Inc.
Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...
Philadelphia, United Stat...
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
Gaithersburg, United Stat...
About Laminar Pharma
Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs.
Design and development of drugs based on melitherapy, Conducting clinical trials, Providing expanded access policies for drug therapies, Collaboration with scientific and medical communities
Patients with unmet medical needs, Healthcare providers, Pharmaceutical investors, Scientific and clinical research professionals
Biopharmaceutical, Membrane-Lipid Therapy, Drug Discovery, Rational Drug Design, Clinical Development, Cancer Treatment, CNS Disorders, Inflammatory Diseases, Metabolic Diseases, Peripheral Proteins, Signal Transduction Modulation, Glioblastoma Treatment, Neurodegenerative Diseases, Spin-off, Therapeutic Strategy
B2B, White Label
Licensing, Product Sales
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Laminar Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Laminar Pharma on 8 Apr 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.